Correlation of s-CD44 With 7 Clinical Factors in DLCL
| Variable . | s-CD44* . | P Value . | |
|---|---|---|---|
| . | ≤493 ng/mL . | >493 ng/mL . | . |
| Stage (N = 50) | |||
| I-II | 21 (72) | 8 (28) | .0007 |
| III-IV | 5 (24) | 16 (76) | |
| WHO performance status Z (N = 51) | |||
| 0 | 18 (75) | 6 (25) | .005 |
| 1 | 6 (32) | 13 (68) | |
| 2-4 | 2 (25) | 6 (75) | |
| s-LDH (N = 49) | |||
| ≤450 U/L | 22 (63) | 13 (37) | .009 |
| >450 U/L | 3 (21) | 11 (79) | |
| B symptoms (N = 51) | |||
| No | 22 (58) | 16 (42) | .09 |
| Yes | 4 (31) | 9 (69) | |
| Age (N = 51) | |||
| ≤59 yr | 15 (63) | 9 (38) | .12 |
| >59 yr | 11 (41) | 16 (59) | |
| No. of extranodal sites (N = 50) | |||
| 0-1 | 24 (57) | 18 (43) | .13 |
| >1 | 2 (25) | 6 (75) | |
| Gender (N = 51) | |||
| Male | 14 (61) | 9 (39) | .20 |
| Female | 12 (43) | 16 (57) | |
| Variable . | s-CD44* . | P Value . | |
|---|---|---|---|
| . | ≤493 ng/mL . | >493 ng/mL . | . |
| Stage (N = 50) | |||
| I-II | 21 (72) | 8 (28) | .0007 |
| III-IV | 5 (24) | 16 (76) | |
| WHO performance status Z (N = 51) | |||
| 0 | 18 (75) | 6 (25) | .005 |
| 1 | 6 (32) | 13 (68) | |
| 2-4 | 2 (25) | 6 (75) | |
| s-LDH (N = 49) | |||
| ≤450 U/L | 22 (63) | 13 (37) | .009 |
| >450 U/L | 3 (21) | 11 (79) | |
| B symptoms (N = 51) | |||
| No | 22 (58) | 16 (42) | .09 |
| Yes | 4 (31) | 9 (69) | |
| Age (N = 51) | |||
| ≤59 yr | 15 (63) | 9 (38) | .12 |
| >59 yr | 11 (41) | 16 (59) | |
| No. of extranodal sites (N = 50) | |||
| 0-1 | 24 (57) | 18 (43) | .13 |
| >1 | 2 (25) | 6 (75) | |
| Gender (N = 51) | |||
| Male | 14 (61) | 9 (39) | .20 |
| Female | 12 (43) | 16 (57) | |
The median (493 ng/mL) was used as the cut-off value.
Values are the number of patients with the percentage in parentheses.